| Hans-Günter Meyer-Thompson | Naltrexon
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA.
Drug Alcohol Depend. 2018 Apr 10;187:171-178. doi: 10.1016/j.drugalcdep.2018.02.023
https://www.drugandalcoholdependence.com/article/S0376-8716(18)30185-6/fulltext